Webinar 05: “Preclinical modelling in Immuno-oncology: An industry perspective from Toxicology to IND”.

Date: October 15^th, 2024.
Time: 14.00-16.00 CET

14:00-14:10 – Brief introduction by WG5 leaders (Dr. Barbara Breznick and Prof. Rosalinda Sorrentino) and Prof. Emmet Mc Cormack (University of Bergen, Norway)

14:10-14:30 – Preclinical development of immunoncology therapeutics in humanized mice

Dr. Michael Boice, Senior Director, Scientific Engagement, Certis Oncology Solutions, San Diego, USA

14:30-14:50 –Preclinical development of small molecule immunoncology therapeutics – A pharma perspective

Dr. Katarzyna Wnuk-Lipinska, Novartis Biomedical Research, Basel, Switzerland

14:50-15:10 – Development of immunoncology therapeutics in preparation for IND.

Dr. Hillary Millar Quinn, Director of In Vivo Pharmacology at Century Therapeutics Inc., Philadelphia, USA

15:10-16:00 – Q&A-Discussion

Register here: https://forms.gle/qnP7pKeQRpvou7CB6

Zoom link: https://us06web.zoom.us/j/84165588158?pwd=SYPfabSO49MuRgrbPl1EDau12DWzCL.1
Webinar ID: 841 6558 8158
Passcode:705745